EMEA-002469-PIP01-18

Key facts

Active substance
Pyrimidinyl-aminopyridine dual leucine zipper kinase inhibitor (GDC-0134)
Therapeutic area
Neurology
Decision number
P/0099/2019
PIP number
EMEA-002469-PIP01-18
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of amyotrophic lateral sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Roche Registration GmbH

Tel. +41 6168 79411
E-mail: global.paediatrics@roche.com

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating